Skip to main content

2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 17, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 17, 2024 -- From 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Stroke.

Victor Lomachinsky Torres, M.D., from Massachusetts General Hospital in Boston, and colleagues analyzed a 20 percent sample of U.S. Medicare claims from April 1, 2013, to Sept. 30, 2021, to examine prescription patterns of benzodiazepines at the national level. Beneficiaries aged 65 years or older discharged alive following an AIS who had traditional Medicare coverage and six months of prior enrollment in Parts A, B, and D were included. Data were analyzed for 126,050 beneficiaries (mean age, 78 years).

The researchers found that 4.9 percent of beneficiaries initiated a benzodiazepine within 90 days. Lorazepam and alprazolam were the most prescribed new prescriptions (40 and 33 percent, respectively). Overall, 76 and 55 percent of first fills had a day's supply over seven days and between 15 and 30 days, respectively. Initiation rates were higher for women than men (5.5 and 3.8 percent, respectively). Rates were highest in the Southeast (5.1 percent) and lowest in the Midwest (4.0 percent). From 2013 to 2021, there was a modest nationwide decline in initiation (cumulative incidence difference, 1.6 percent).

"Despite an overall downward trend of benzodiazepine initiation among AIS survivors, we noted a concerning possible overuse pattern of benzodiazepine prescriptions dispensed to patients within 90 days of discharge," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted October 2024

Read this next

Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise

WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010...

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.